Knorpelregister DGOU: Wichtiger Beitrag zur Versorgungsforschung

Als ergänzenden Baustein zur Beurteilung der Wertigkeit von Knorpeloperationen und zur Erfassung von Komplikationen hat die AG Klinische Geweberegeneration der DGOU das KnorpelRegister DGOU initiiert. Es steht bislang den Mitgliedern der AG Klinische Geweberegeneration der DGOU zur Verfügung, eine allgemeine Öffnung wird für Mitte des Jahres angestrebt.

• Literatur

• 1 Behrens P et al. Indikations- und Durchführungsempfehlungen der Arbeitsgemeinschaft „Geweberegeneration und Gewebeersatz” zur Autologen Chondrozyten-Transplantation (ACT). Z Orthop Ihre Grenzgeb 2004; 142: 529-539
• 2 Niemeyer P et al. Stellenwert der autologen Chondrozytentransplantation (ACT) in der Behandlung von Knorpelschäden des Kniegelenks – Empfehlungen der AG Klinische Geweberegeneration der DGOU. Zeitschrift fur Orthopadie und Unfallchirurgie 2013; 151: 38-47
• 3 Knutsen G et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 2007; 89: 2105-2112
• 4 Knutsen G et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am 2004; 86-A [phone]
• 5 Saris DB et al. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med 2009; 37 (Suppl. 01) 10S-19S
• 6 Saris DB et al. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med 2008; 36: 235-246
• 7 Vanlauwe J et al. Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am J Sports Med 2011; 39: 2566-2574
• 8 Engen CN, Engebretsen L, Arøen A. Knee Cartilage Defect Patients Enrolled in Randomized Controlled Trials Are Not Representative of Patients in Orthopedic Practice. Cartilage 2010; 1: 312-319
• 9 Sanson-Fisher RW, Bonevski B, Green LW, D'Este C. Limitations of the randomized controlled trial in evaluating population-based health interventions. American journal of preventive medicine 2007; 33: 155-161
• 10 Yang W et al. Observational studies: going beyond the boundaries of randomized controlled trials. Diabetes research and clinical practice 2010; 88 (Suppl. 01) S3-S9
• 11 Mithoefer K et al. Guidelines for the Design and Conduct of Clinical Studies in Knee Articular Cartilage Repair: International Cartilage Repair Society Recommendations Based on Current Scientific Evidence and Standards of Clinical Care. Cartilage 2011; 2: 100-121
• 12 Roos EM, Bremander AB, Englund M, Lohmander LS. Change in self-reported outcomes and objective physical function over 7 years in middle-aged subjects with or at high risk of knee osteoarthritis. Annals of the rheumatic diseases 2008; 67: 505-510
• 13 Roos EM, Davis A, Beynnon BD. IKDC or KOOS? Which measures symptoms and disabilities most important to postoperative articular cartilage repair patients?. Am J Sports Med 2009; 37 (05) 1042-1043 author reply 1043
• 14 Roos EM et al. ICRS Recommendation Document: Patient-Reported Outcome Instruments for Use in Patients with Articular Cartilage Defects. Cartilage 2011; 2: 122-136
• 15 Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. J Orthop Sports Phys Ther 1998; 28: 88-96